Omnitrust Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Omnitrust Wealth Management's LLY Position: Q1 2026 in Review
Omnitrust Wealth Management reduced its Eli Lilly (LLY) stake by 1.3% in Q1 2026, selling an estimated $4.05K and leaving 314 shares worth $289K. The position accounts for 0.37% of the portfolio, ranked #41.
Omnitrust Wealth Management first reported a position in LLY in Q2 2025 and has held it in 3 quarters since. The position peaked at $342K in Q4 2025. 4,379 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Omnitrust Wealth Management held 314 shares of Eli Lilly worth $289K as of Q1 2026.
- Omnitrust Wealth Management sold 4 Eli Lilly shares in Q1 2026, an estimated $4.05K.
- Eli Lilly made up 0.37% of Omnitrust Wealth Management's portfolio in Q1 2026, its #41 holding.
- Omnitrust Wealth Management first reported a position in Eli Lilly in Q2 2025 and has held it in 3 quarters since.
- Omnitrust Wealth Management's Eli Lilly position peaked at $342K in Q4 2025.
- 4,379 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Omnitrust Wealth Management's 13F filing for Q1 2026, filed 23 Apr 2026.